Whitehawk Therapeutics (WHWK) Total Current Liabilities (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Total Current Liabilities data on file, last reported at $11.1 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $11.1 million, down 9.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (down 9.92% YoY), and the FY2025 annual result was $14.5 million, down 14.96% from the prior year.
• Total Current Liabilities eased to $11.1 million in Q1 2026 per WHWK's latest filing, from $14.5 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $26.4 million in Q4 2023 and troughed at $8.8 million in Q2 2025.
• A 5-year average of $15.9 million and a median of $15.8 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 470.45% in 2022, then plunged 60.46% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $18.8 million in 2022, then jumped by 40.14% to $26.4 million in 2023, then tumbled by 35.31% to $17.1 million in 2024, then decreased by 14.96% to $14.5 million in 2025, then retreated by 23.85% to $11.1 million in 2026.
• Business Quant data shows WHWK's Total Current Liabilities at $11.1 million in Q1 2026, $14.5 million in Q4 2025, and $9.8 million in Q3 2025.